Bacillus Calmette-Guérin (BCG) vaccine has gained worldwide recognition as a safe vaccine to fight tuberculosis (TB). The live attenuated vaccine form of Mycobacterium bovis, the etiological agent of TB, has also been used in various immunization programs worldwide. This is also due to their effectiveness in fighting off several other mycobacterial infections, with Buruli ulcer disease being a notable example. The BCG vaccines sales market has been strikingly shaped by the recurrent mismatch between the demand and supply, a concern has remained almost consistent over the decades. The persistent problem of stock-outs has impacted the course of sales of BCG vaccines in low-and-middle income countries, especially. Globally, Expanded Programme on Immunization (EPI) has determined the dynamic of supply to economies. This has greatly impacted the BCG vaccines sales market. Of note, even several high-income countries (HICs) have recently suffered from the paucity in supply. The stock-outs are a fallout of a few microeconomic factors as well as some macroeconomic environmental factors.
Good manufacturing practices (GMP) issues faced by manufacturers constitute of the key macroenvironmental factors shaping dynamics in BCG vaccines sales market. On another front, frequent halt in production, uncertainty in supply of raw materials, and lack of commensurate advancements in production technologies are some of the prominent bottlenecks for continued sales of these vaccines. Redesigning of the production process may be imperative in the backdrop of the steadily rising BCG vaccines sales.
Global BCG Vaccines Sales Market: Overview
The demand within the global BCG vaccines sales market has been rising on account of the rising concern for protecting new-borns from severe diseases. BCG vaccines, in essence, are used to immune individuals of tuberculosis, and other similar diseases. Hence, the global BCG vaccines sales market is projected to reek of growth in the years to come. The demand for BCG vaccines sales has existed since the very inception of such vaccines. This is because the medical fraternity has been extremely responsive to the availability of new vaccines and treatment mechanisms. It is expected that improvements in the domain of vaccinations would propel demand within the global BCG vaccines sales market.
Several new vendors have come to the fore of the global BCG vaccines sales market in recent times. The developments made in the field of vaccinations have been accolade by medical practitioners and doctors. This trend has reflected in the growth of the global BCG vaccines sales market in recent times. Moreover, the presence of a separate domain for vaccination within healthcare has also generated ripples across the global market. It is expected that the total value of the global BCG vaccines sales market would increase to new heights in the years to come.
The global BCG vaccines sales market can be segmented on the basis of the following parameters: drug type, usage, end-user, and region. On the basis of drug type, the global BCG vaccines sales market can be segmented into immune BCG and therapy BCG. The demand for therapy BCG has superseded the demand for immune BCG majorly due to the rising incidence of tuberculosis. On the basis of end-user, the global BCG vaccines sales can be segmented into adults and paediatrics.
Global BCG Vaccines Sales Market: Notable Developments
The leading vendors within the global BCG vaccines sales market have made strategic developments in recent times:
The competitive dynamics of the global BCG vaccines sales market are expected to improve in the years to come.
Global BCG Vaccines Sales Market: Growth Drivers
The global market for BCG vaccines sales has been rising on account of advancements in the vaccination camps. Several online and offline campaigns, aimed at informing the masses about proper vaccination, have come to the fore in recent times. This factor has directly contributed towards the growth of the global BCG vaccines sales market in recent times. Furthermore, the need for a seamless industry for BCG vaccines has also aided market growth.
New-born babies are prone to catching several infections and viruses. For this reason, a number of new-borns suffer from tuberculosis and other similar diseases. This factor has played a major role in the growth of the global BCG vaccines sales market in recent times.
Global BCG vaccines sales Market: Regional Outlook
On the basis of geography, the global BCG vaccines sales market has been segmented into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. The market for BCG vaccines sales in North America has been expanding alongside increasing impetus given on immunization in the US.